Benoı̂t Blanchet

Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes

Jean‐Philippe Collet, Gilles Montalescot, Benoı̂t Blanchet et al. · Circulation · 2004 · 369 citations

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

Olivier Mir, Romain Coriat, Benoı̂t Blanchet et al. · PLoS ONE · 2012 · 294 citations · Full text

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

M. Jallouli, Lionel Galicier, Noël Zahr et al. · Arthritis & Rheumatology · 2015 · 135 citations

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice

Benoı̂t Blanchet, Bertrand Billemont, Julie Cramard et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 118 citations

Sorafenib Determination, Oncology, Cancer Detection +11

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux‐Leprieur et al. · Cancers · 2020 · 110 citations · Full text